Search - tctmd.com

Displaying 181 - 200 of 1241

Sort: Relevancy | Date

Myriad Novel Devices Aim to Boost Decongestion in Acute HF

News Features

Myriad Novel Devices Aim to Boost Decongestion in Acute HF

April 10, 2023

MR CLEAN-LATE Affirms 24-Hour Window Safe for Endovascular Stroke Therapy

News Daily News

MR CLEAN-LATE Affirms 24-Hour Window Safe for Endovascular Stroke Therapy

Yael L. Maxwell

April 07, 2023

Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI

News Daily News

Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI

Michael O'Riordan

March 31, 2023

More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field

News Conference News THT 2023

More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field

March 24, 2023

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

News Conference News THT 2023

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Yael L. Maxwell

March 22, 2023

Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF

News Conference News THT 2023

Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF

March 22, 2023

The PRELIEVE trial: Responder analysis in the HFpEF subgroup regarding baseline PVR, pacemaker and pressure gradients

Presentation THT 2023

The PRELIEVE Trial: Responder Analysis in the HFpEF Subgroup Regarding Baseline PVR, Pacemaker and Pressure Gradients

Presenter: NULL

March 22, 2023

Pulmonary Artery Denervation Makes Inroads in PAH Due to Left-Sided HF

News Conference News THT 2023

Pulmonary Artery Denervation Makes Inroads in PAH Due to Left-Sided HF

March 21, 2023

PCI’s Role for Patients With HFrEF and Extensive CAD: Experts Debate

News Conference News THT 2023

PCI’s Role for Patients With HFrEF and Extensive CAD: Experts Debate

March 20, 2023

Presentation THT 2023

The PRELIEVE trial: Final 1-year outcomes of the prospective Atrial Flow Regulator study in HFrEF and HFpEF patients and post-hoc responder analysis

Presenter: Christina Paitazoglou

March 20, 2023

Mediterranean Diet’s CV Benefits Extend to Women: Meta-analysis

News Daily News

Mediterranean Diet’s CV Benefits Extend to Women: Meta-analysis

March 15, 2023

STREAM-2: Half-Dose Tenecteplase Safe, Effective in Older STEMI Patients

News Conference News ACC 2023

STREAM-2: Half-Dose Tenecteplase Safe, Effective in Older STEMI Patients

March 10, 2023

AIMI-HF Misses Mark With Advanced Imaging in Ischemic HFrEF Workup

News Conference News ACC 2023

AIMI-HF Misses Mark With Advanced Imaging in Ischemic HFrEF Workup

March 09, 2023

Multifaceted Approach to COORDINATE Diabetes Care Improves GDMT

News Conference News ACC 2023

Multifaceted Approach to COORDINATE Diabetes Care Improves GDMT

Yael L. Maxwell

March 07, 2023

STELLAR, ‘Impressive’ Results With Novel Drug Sotatercept in PAH

News Conference News ACC 2023

STELLAR, ‘Impressive’ Results With Novel Drug Sotatercept in PAH

March 06, 2023

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

News Conference News ACC 2023

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

March 04, 2023

European Societies Define Best Practices for Performing Renal Denervation

News Daily News

European Societies Define Best Practices for Performing Renal Denervation

February 21, 2023

Does All AF After Stroke Warrant Anticoagulation? Experts Debate

News Conference News ISC 2023

Does All AF After Stroke Warrant Anticoagulation? Experts Debate

February 17, 2023

Go Red for Women: Nearly 20 Years of Much Progress, Some Setbacks

News Features

Go Red for Women: Nearly 20 Years of Much Progress, Some Setbacks

February 03, 2023

Political Donations From ACC’s HeartPAC Approach Pre-January 6 Levels

News Daily News

Political Donations From ACC’s HeartPAC Approach Pre-January 6 Levels

January 27, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.